Aspirin and clopidogrel for prevention of ischemic stroke.

Abstract

This review examines the role of platelets in ischemic stroke, platelet activation mechanisms, aspirin's rise as an antithrombotic agent, clopidogrel's appearance on the stage, a possible role for combination therapy, antiplatelet resistance, practical considerations, and future directions. Reviewed in this chapter are issues central to optimal antiplatelet therapy: efficacy, safety, resistance, and biochemical/laboratory testing. Current guidelines do not recommend combination aspirin and clopidogrel use, however recent research indicates dual antiplatelet therapy with combined aspirin and clopidogrel may have specific roles in secondary prevention of ischemic stroke. A cautious and analytical interpretation of the literature is advised before application of this knowledge to clinical practice. The best recommendation at this time is to follow the published guidelines for secondary prevention of ischemic stroke.

DOI: 10.1007/s11910-012-0327-y
05010015020132014201520162017
Citations per Year

136 Citations

Semantic Scholar estimates that this publication has 136 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Thomson2013AspirinAC, title={Aspirin and clopidogrel for prevention of ischemic stroke.}, author={R. C. Muirhead Thomson and David C. Anderson}, journal={Current neurology and neuroscience reports}, year={2013}, volume={13 2}, pages={327} }